Stock Price

A bitter proxy fight erupts at Fermi Inc., pitting its founder against the board. At stake is not just the company, but its ambitious AI power grid project.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

Amid widening losses and a squeezed consumer, the children's retailer is monetizing assets and cutting deep into its supply chain. A new team bets on it being enough.

A missing miner at Kootenay's Columba project puts a human face on the risks of a booming silver market and tests corporate safety in Mexico.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

FCPT's latest acquisition seems minor, but it reveals a powerful strategy for navigating economic uncertainty by targeting essential, service-based real estate.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

Tokyo-based CTW, a leader in web-based anime games, is pitching to US microcap funds. What's the strategy behind this cross-border play for capital?

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.

Hyperscale Data is deploying humanoid robots in its Michigan data center, a high-stakes bet to teach AI about the real world amid major financial pressures.

American Outdoor Brands faces a key test on June 25. With mixed results and a shifting market, can its innovation strategy deliver on investor hopes?

As Federal Realty preps its Q2 report, investors are watching if its 58-year dividend streak and mixed-use strategy can defy market headwinds.

Beyond solar panels and ESG reports, JFK's $9.5B New Terminal One is a blueprint for climate-proof infrastructure. Here’s why it redefines the 2026 travel experience.

AIFU, a Chinese fintech firm on the brink, plans to acquire a waste-tech AI company. Is this a visionary leap into green industry or a desperate gamble?

With a promising cancer therapy but precarious finances, Propanc Biopharma's stock buyback raises a critical question: is it a sign of confidence or a high-stakes gamble?

RenX just wiped $7M of debt in a savvy insider deal. It’s more than a balance sheet fix—it’s a calculated bet on a tech-driven, sustainable future.

FreeCast's expanded DIRECTV deal aims to empower local providers and simplify streaming. But can this ambitious PaaS model overcome steep financial hurdles?

Vision Marine's hands-on demos at a key California festival show that the future of boating isn't just talk; it's about experience, infrastructure, and policy.

A Nasdaq non-compliance notice threatens BIO-key's listing, revealing a pattern of reporting delays that casts a shadow over its operational wins.

Canada Nickel secures C$6.2M for its 'NetZero Nickel' vision, but a steep 15% interest rate on a major loan reveals the high cost of its green ambitions.